risks of glp-1 Long-Term Effects Medications: What You Should Know Unlocking the broad health benefits
Description
For many Americans, the barrier hasn't been a lack of awareness or willingness to improve their health
[DOI] [PubMed] [Google Scholar] 188.Rahman M.M., et al
Lancet Diabet Endocrinol 11:3341
However, the STEP4 trial demonstrated that weight loss from semaglutide is not sustained, and study participants who were switched to placebo after 20 weeks regained 6.9% of their body weight by 68 weeks (Rubino et al., 2021)
The severity and frequency of prior diverticulitis episodes matter significantly when evaluating semaglutide safety
